Bijoy Hans Ltd
₹ 24.2
5.00%
14 Aug
- close price
About
Incorporated in 1985, Bijoy Hans Ltd is in the business of Pharmaceutical, Medical and Cosmetics goods[1]
Key Points
- Market Cap ₹ 18.1 Cr.
- Current Price ₹ 24.2
- High / Low ₹ 24.2 / 24.2
- Stock P/E
- Book Value ₹ 11.8
- Dividend Yield 0.00 %
- ROCE -10.6 %
- ROE -12.1 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Promoter holding has increased by 55.4% over last quarter.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -10.6% over past five years.
- Company has a low return on equity of -10.5% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.33 | 0.35 | 0.42 | 1.33 | 0.44 | 0.40 | 0.49 | 0.40 | 0.33 | 0.30 | 0.28 | 0.28 | 0.19 | |
| 0.52 | 0.56 | 0.67 | 1.61 | 0.72 | 0.65 | 0.74 | 0.66 | 0.63 | 0.82 | 0.64 | 0.79 | 0.90 | |
| Operating Profit | -0.19 | -0.21 | -0.25 | -0.28 | -0.28 | -0.25 | -0.25 | -0.26 | -0.30 | -0.52 | -0.36 | -0.51 | -0.71 |
| OPM % | -57.58% | -60.00% | -59.52% | -21.05% | -63.64% | -62.50% | -51.02% | -65.00% | -90.91% | -173.33% | -128.57% | -182.14% | -373.68% |
| 0.30 | 0.29 | 0.27 | 0.23 | 0.25 | 0.23 | 0.24 | 0.21 | 0.15 | 0.14 | 0.30 | 0.74 | 0.73 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.08 | 0.09 | 0.07 | 0.07 | 0.08 | 0.06 | 0.05 | 0.04 | 0.03 | 0.06 | 0.05 | 0.02 | 0.02 |
| Profit before tax | 0.03 | -0.01 | -0.05 | -0.12 | -0.12 | -0.08 | -0.06 | -0.09 | -0.18 | -0.45 | -0.12 | 0.20 | -0.01 |
| Tax % | 0.00% | -100.00% | 0.00% | 0.00% | -8.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 30.00% | |
| 0.04 | 0.00 | -0.05 | -0.13 | -0.11 | -0.08 | -0.05 | -0.09 | -0.19 | -0.44 | -0.12 | 0.14 | -0.07 | |
| EPS in Rs | 0.13 | 0.00 | -0.17 | -0.43 | -0.37 | -0.27 | -0.17 | -0.30 | -0.63 | -1.47 | -0.40 | 0.47 | 0.27 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -11% |
| 3 Years: | -5% |
| TTM: | -37% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -133% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 3% |
| 1 Year: | 5% |
| Return on Equity | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -7% |
| 3 Years: | -11% |
| Last Year: | -12% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Reserves | 1.75 | 1.75 | 1.70 | 1.48 | 1.36 | 1.28 | 1.23 | 1.14 | 0.95 | 0.51 | 0.39 | 0.53 |
| 0.00 | 0.00 | 0.00 | 0.09 | 0.06 | 0.02 | 0.00 | 0.00 | 0.00 | 0.08 | 0.06 | 0.00 | |
| 0.10 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.06 | |
| Total Liabilities | 4.85 | 4.77 | 4.72 | 4.60 | 4.44 | 4.33 | 4.27 | 4.17 | 3.99 | 3.63 | 3.49 | 3.59 |
| 0.95 | 0.87 | 0.86 | 0.91 | 0.88 | 0.82 | 0.78 | 0.74 | 0.71 | 0.76 | 0.40 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.24 | 0.19 | 0.19 | 0.09 | 0.12 | 0.05 | 0.05 | 0.05 | 0.14 | 0.20 | 0.38 | 0.13 |
| 3.66 | 3.71 | 3.67 | 3.60 | 3.44 | 3.46 | 3.44 | 3.38 | 3.14 | 2.67 | 2.71 | 3.46 | |
| Total Assets | 4.85 | 4.77 | 4.72 | 4.60 | 4.44 | 4.33 | 4.27 | 4.17 | 3.99 | 3.63 | 3.49 | 3.59 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.09 | 0.13 | -0.15 | -0.40 | -0.10 | 0.02 | -0.07 | -0.01 | -0.37 | -0.26 | -0.29 | 0.22 | |
| 0.04 | 0.01 | -0.06 | -0.12 | -0.04 | 0.00 | -0.01 | 0.00 | 0.00 | -0.11 | 0.32 | 0.92 | |
| 0.00 | 0.00 | 0.00 | 0.09 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | 0.08 | -0.02 | -0.06 | |
| Net Cash Flow | -0.05 | 0.14 | -0.22 | -0.43 | -0.14 | 0.03 | -0.10 | -0.02 | -0.37 | -0.29 | 0.01 | 1.08 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 110.61 | 83.43 | 60.83 | 30.19 | 82.95 | 91.25 | 126.63 | 118.62 | 88.48 | 109.50 | 104.29 | 0.00 |
| Inventory Days | 104.29 | 116.80 | 130.36 | 51.68 | 105.97 | 102.20 | 57.03 | 121.67 | 111.09 | 69.52 | 86.90 | 0.00 |
| Days Payable | 34.76 | 29.20 | 26.07 | 9.69 | 23.55 | 29.20 | 45.62 | 36.50 | 63.48 | 69.52 | 0.00 | |
| Cash Conversion Cycle | 180.13 | 171.03 | 165.12 | 72.18 | 165.37 | 164.25 | 138.04 | 203.79 | 136.09 | 109.50 | 191.19 | 0.00 |
| Working Capital Days | 575.15 | 521.43 | 582.26 | 255.23 | 796.36 | 894.25 | 513.98 | 438.00 | 940.15 | 206.83 | 234.64 | 273.75 |
| ROCE % | -0.21% | -0.84% | -1.27% | -2.59% | -2.89% | -1.83% | -1.41% | -2.15% | -4.45% | -11.67% | -7.10% | -10.60% |
Documents
Announcements
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 1d
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 2d
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 18 Aug
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 18 Aug
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
13 Aug - Disclosure of sale of 49,200 shares (0.66%) via off-market transaction per Dec 2024 agreement.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
Company does Wholesale of Pharmaceutical and Medical Goods and Cosmetics. It offers various pharmaceutical formulations such as tablets, capsules, syrups, suspension and powders, focusing on segments viz. Antibiotics, Cough/cold/allergy, H-1 receptor Antagonist (Antiulcerant), Nutraceutical, and NSAIDS